AHCLNSEAnlon Healthcare LimitedMediumNeutral
Announced Thu, 16 Apr · 14:17 IST

Anlon Healthcare Limited has informed the Exchange about Agreements

Listed Co AcquisitionStrategic Transactions View source PDF

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.9%1-day move
₹13.88
prior close
₹14.09
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2+0.1+0.1+1.9+4.4+1.8+4.8+4.0+2.7+0.9-1.4+16.2+9.9
Up moveDown movePending
AI summary

Anlon Healthcare Limited has entered into a share purchase agreement to acquire 63.98% shareholding in Remember India Health Links Private Limited for Rs. 5,38,12,800 in cash. The target company is engaged in manufacturing pharmaceutical finished products like tablets and capsules. Upon completion, Remember India Health Links will become a subsidiary of Anlon Healthcare. The deal is expected to close within 4-5 months and is not a related party transaction. The acquisition aims to transform Anlon from an API (Active Pharmaceutical Ingredient) manufacturer into a complete pharmaceutical provider, expanding into finished dosage formulations and gaining access to over 30 dossiers.

Likely market impact

This acquisition enables Anlon Healthcare to diversify from B2B ingredient supply into finished dosage formulations and retail/hospital markets. While the target's turnover is modest (Rs. 83 lakh FY25), the strategic move into FDFs could broaden the company's revenue base and market positioning.